MKI67 and neoplasm: In addition, this observation was supported by the cell proliferation marker Ki67/DAPI ratio, which was significantly reduced (p = 0.0015) in TTFields- and PTX-treated rats compared to TTFields alone, alongside a strongly reduced proliferation rate of tumor cells after the combined treatment (Figure 6D,E).